Publications by authors named "Maria Di Perna"

Claim this Profile
E
Efficacy of Momelotinib in Myelofibrosis Patients: Results From a Multicenter Study.
Maria Carmen Martorelli, Novella Pugliese, Maria Di Perna, Danilo De Novellis, Assunta Lombardi

Eur J Haematol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Luspatercept treatment affects immune-regulatory subsets in patients with MDS with ring sideroblasts.
Stefania Leone, Francesco Grimaldi, Mara Memoli, Giulia Scalia, Annamaria Vincenzi, Maria Di Perna

Blood Neoplasia· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Italian real-world multicenter study of patients with refractory/relapsed functional high-risk multiple myeloma patients treated with second-line therapies.
Danilo De Novellis, Salvatore Palmieri, Stefano Rocco, Daniele Derudas, Roberta Della Pepa, Maria Di Perna

Ann Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring thromboembolic risk factors in polycythemia vera: from current evidence to PROSPERO study design.
Valerio De Stefano, Francesco Passamonti, Francesca Palandri, Francesco Ramundo, Elena Rossi, Maria Di Perna

Ann Hematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients.
Danilo De Novellis, Daniele Derudas, Donatella Vincelli, Raffaele Fontana, Roberta Della Pepa, Maria Di Perna

Eur J Haematol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders: A Multicenter Real-Life Experience.
Danilo De Novellis, Raffaele Fontana, Salvatore Palmieri, Roberta Della Pepa, Maria Di Perna

Target Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of belantamab-mafodotin in triple-refractory multiple myeloma patients: A multicentric real-life experience.
Rossella Iula, Danilo De Novellis, Fabio Trastulli, Roberta Della Pepa, Raffaele Fontana, Maria Di Perna

Front Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pegfilgrastim in primary prophylaxis of febrile neutropenia in elderly patients with hematological malignancies-bendamustine and G-CSF support.
Claudio Cerchione, Amalia De Renzo, Davide Nappi, Maria Di Perna, Roberta Della Pepa

Support Care Cancer· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tenofovir vs lamivudine for the prevention of hepatitis B virus reactivation in advanced-stage DLBCL.
Marco Picardi, Roberta Della Pepa, Claudia Giordano, Irene Zacheo, Novella Pugliese, Maria Di Perna

Blood· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab in a risk-adapted treatment strategy gives excellent therapeutic results in nodular lymphocyte-predominant Hodgkin lymphoma.
Roberta Della Pepa, Marco Picardi, Claudia Giordano, Irene Zacheo, Novella Pugliese, Maria Di Perna

Br J Haematol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and comfort of domestic bortezomib injection in real-life experience.
Claudio Cerchione, Davide Nappi, Anna Emanuele Pareto, Maria Di Perna, Irene Zacheo

Support Care Cancer· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of efficacy of bendamustine in heavily pretreated multiple myeloma, refractory to pomalidomide.
Claudio Cerchione, Davide Nappi, Maria Di Perna, Irene Zacheo, Ilaria Migliaccio

Clin Case Rep· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experience.
Claudio Cerchione, Amalia De Renzo, Maria Di Perna, Roberta Della Pepa, Novella Pugliese

Support Care Cancer· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing neutropenia by pegfilgrastim in patients affected by relapsed/refractory multiple myeloma treated with bendamustine-bortezomib-dexamethasone.
Claudio Cerchione, Lucio Catalano, Ilaria Peluso, Davide Nappi, Maria Di Perna

Support Care Cancer· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retreatment with Bendamustine-Bortezomib-Dexamethasone in a Patient with Relapsed/Refractory Multiple Myeloma.
Claudio Cerchione, Davide Nappi, Maria Di Perna, Irene Zacheo, Anna Emanuele Pareto

Case Rep Hematol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis